Bullisch
$137.73
Szenariopreis
$216.980
-3.732 (-1.72%)Zum Schluss
Plexus Corp. is engaged in providing design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services. The Company's design and development capabilities include product strategy, product development, design for excellence (DFX), and test engineering. Its new product introduction capabilities include DFX, transition management, test engineering, supply chain management, and rapid prototype. Its manufacturing capabilities include end-to-end manufacturing, integrated test and inspection, fulfillment and logistics. Its supply chain capabilities include early engagement and early engagement. Its sustaining service capabilities include distribution management, product life cycle extension, aftermarket services, repair and refurbishment. It serves the aerospace, defense, security, space, advanced surgical systems, medical robotics, life sciences, diagnostics, medical devices and equipment sectors.
Plexus Corp is currently priced at $216.98, which is significantly below the average analyst price target of $300 to $330, indicating potential upside. However, the RSI is at a very low 16.98, suggesting the stock is oversold, which could present a buying opportunity. The recent 5-day change is -5.85%, reflecting short-term weakness, while the year-to-date change is +42.53%, indicating strong long-term performance. The main risk is the insider selling activity, which has increased by 1088.24% over the last month, potentially signaling concerns about future performance.
KeyBanc
$300
2026-09-21
KeyBanc
2026-09-21
Kursziel
$300
Sidoti
$308
2026-07-31
Sidoti
2026-07-31
Kursziel
$308
Stifel
$330
2026-06-22
Stifel
2026-06-22
Kursziel
$330
Needham
$310
2026-06-01
Needham
2026-06-01
Kursziel
$310
Stifel
$280
2026-05-01
Stifel
2026-05-01
Kursziel
$280
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

Plexus to Release Q4 and FY 2026 Earnings Results

Keybanc Upgrades Plexus to Overweight Rating

Latest Wall Street Ratings and Price Target Analysis

Plexus Executive Sells 500 Shares of Stock

Plexus Director Sells 500 Shares of Stock
Plexus Corp. is engaged in providing design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services. The Company's design and development capabilities include product strategy, product development, design for excellence (DFX), and test engineering. Its new product introduction capabilities include DFX, transition management, test engineering, supply chain management, and rapid prototype. Its manufacturing capabilities include end-to-end manufacturing, integrated test and inspection, fulfillment and logistics. Its supply chain capabilities include early engagement and early engagement. Its sustaining service capabilities include distribution management, product life cycle extension, aftermarket services, repair and refurbishment. It serves the aerospace, defense, security, space, advanced surgical systems, medical robotics, life sciences, diagnostics, medical devices and equipment sectors. It operates in the Technology sector (PRINTED CIRCUIT BOARDS industry).
Plexus Corp is currently priced at $216.98, which is significantly below the average analyst price target of $300 to $330, indicating potential upside. However, the RSI is at a very low 16.98, suggesting the stock is oversold, which could present a buying opportunity. The recent 5-day change is -5.85%, reflecting short-term weakness, while the year-to-date change is +42.53%, indicating strong long-term performance. The main risk is the insider selling activity, which has increased by 1088.24% over the last month, potentially signaling concerns about future performance.
8 analysts cover PLXS: 1 rate it Buy, 6 Hold and 1 Sell. The average price target is 208.67.
Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.